Replies to Post #19973 onIntellect Neurosciences Inc. (fka ILNS) | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Replies to post #19973 on Intellect Neurosciences Inc. (fka ILNS)

Replies to #19973 on Intellect Neurosciences Inc. (fka ILNS)

05/11/16 9:09 AM

#19974 RE: montanus #19973

RN6g phase 2 trial results have been removed from public view

https://www.clinicaltrialsregister.eu/ctr-search/search?query=rn6g

05/11/16 11:21 AM

#19976 RE: montanus #19973

GSK completed GSK933776 (anti Aß peptide, n-terminus ) AMD phase 2 trial last month.
Enrolment: 190

https://clinicaltrials.gov/ct2/show/NCT01342926?term=gsk933776&rank=4